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AbSTrACT
Objective To identify and quantify determinants of 
anxiety symptoms and disorders experienced by elite 
athletes.
Design Systematic review and meta-analysis.
Data sources Five online databases (PubMed, 
SportDiscus, PsycINFO, Scopus and Cochrane) were 
searched up to November 2018 to identify eligible 
citations.
Eligibility criteria for selecting studies Articles 
were included if they were published in English, were 
quantitative studies and measured a symptom-level 
anxiety outcome in competing or retired athletes at the 
professional (including professional youth), Olympic or 
collegiate/university levels.
results and summary We screened 1163 articles; 61 
studies were included in the systematic review and 27 of 
them were suitable for meta-analysis. Overall risk of bias 
for included studies was low. Athletes and non-athletes 
had no differences in anxiety profiles (d=−0.11, p=0.28). 
Pooled effect sizes, demonstrating moderate effects, 
were identified for (1) career dissatisfaction (d=0.45; 
higher anxiety in dissatisfied athletes), (2) gender 
(d=0.38; higher anxiety in female athletes), (3) age 
(d=−0.34; higher anxiety for younger athletes) and (4) 
musculoskeletal injury (d=0.31; higher anxiety for injured 
athletes). A small pooled effect was found for recent 
adverse life events (d=0.26)—higher anxiety in athletes 
who had experienced one or more recent adverse life 
events.
Conclusion Determinants of anxiety in elite 
populations broadly reflect those experienced by the 
general population. Clinicians should be aware of these 
general and athlete-specific determinants of anxiety 
among elite athletes.
InTrODuCTIOn
Combined anxiety disorders affect the general 
population at an estimated (past 12 month) rate 
of 10.6%–12.0%,1 2 with broadly similar rates 
suggested among elite athlete populations (8.6%),3 
defined as those competing at professional, Olympic 
or collegiate/university levels. Anxiety disorders are 
characterised by emotional responses associated with 
fear, apprehension, worry and tension in response 
to an actual or perceived threat.4 Anxiety modu-
lates attentional networks, resulting in compro-
mised executive function, stimulus processing and 
information selection5—all important domains 
for elite competition. While commonalities are 
present, diagnostic systems differentiate anxiety 
subtypes, such as generalised anxiety disorder 
(GAD) or social anxiety disorder.4 Additionally, 
anxiety can be a situationally or event-dependent 
transitory state (eg, state anxiety), or a relatively 
stable personality characteristic (eg, trait anxiety). 
State anxiety symptoms are more likely to occur in 
situations perceived as threatening.6
Athlete-specific factors may precipitate or exac-
erbate anxiety disorders, including pressures to 
perform and public scrutiny,7 career uncertainty or 
dissatisfaction,8 9 and injury.10–12 General psychoso-
cial factors are also strongly implicated in the onset 
and maintenance of anxiety disorders within the 
general population. These include behavioural inhi-
bition, social withdrawal or avoidance, and cogni-
tive patterns of rumination.13 A recent meta-analysis 
found that female gender, younger age and lower 
athletic experience were associated with higher 
competitive anxiety in athletes14; however, the 
specific determinants of anxiety disorders in elite 
athlete populations has not yet been reported. 
Identification of putative subgroup differences may 
assist with early identification and indicated preven-
tion efforts in this population, improving the timely 
management of anxiety disorders among elite 
athletes. The objective of this study was to perform 
a systematic review and meta-analysis to identify, 
quantify and analyse determinants of anxiety symp-
toms experienced by elite athletes.
METhOD
The study was conducted in accordance with the 
Preferred Reporting Items for Systematic Reviews 
and Meta-Analyses guidelines.
Search strategy
A systematic search strategy was developed by 
an experienced academic librarian (MEH). The 
search was executed in the PubMed, SportDiscus, 
PsycINFO, Scopus and Cochrane databases from 
inception until November 2018. The search strategy 
and MeSH terms are presented in online supple-
mentary table 1. Citations were independently 
screened by SMR, RP and KG.
Study inclusion
Studies were selected if they included (1) data on 
elite athletes, including para-athletes, defined by 
standard of performance level,15 competing at the 
professional (and professional youth, ie, members 
of elite sports schools), Olympic and collegiate/
university levels; (2) a symptomatic or diagnostic 
anxiety outcome measure (as per the Diagnostic and 




ay 2019 by guest. Protected by copyright.
http://bjsm.bmj.com/
Br J Sports M
ed: first published as 10.1136/bjsports-2019-100620 on 16 May 2019. Downloaded from 
2 of 10 Rice SM, et al. Br J Sports Med 2019;53:722–730. doi:10.1136/bjsports-2019-100620
Systematic review
criteria) in relation to GAD, specific phobia, social anxiety, 
panic disorders or obsessive-compulsive disorder (OCD); and 
(3) currently competing or retired athletes (authors adopted a 
maximum mean retirement length of 10 years to allow investi-
gation of effects between anxiety and longer-term sport-specific 
outcomes [eg, concussion],16 and account for, yet limit the effect 
of retirement).17
Study exclusion
Studies were excluded if they were not published in English, 
were a case study or case report, used a qualitative design, were 
review articles or were not refereed journal articles (confer-
ence abstracts were excluded), or focused solely on state-based 
performance or competitive anxiety (ie, included studies needed 
to report on a measure/diagnosis of symptom-level anxiety as 
per DSM-5).
Assessment of study quality
We assessed quality of studies with the Joanna Briggs Institute’s 
critical appraisal tools for systematic reviews.18 These tools are 
validated appraisal checklists specific to study design, capturing 
aspects of design quality, analysis and reporting. KG assessed 
studies using checklists for randomised controlled trials (RCTs), 
cohort studies, prevalence studies, cross-sectional studies and 
quasi-experimental studies. The appraisal score reported is the 
proportion of ‘yes’ responses on the total number of criteria. If a 
criterion was not applicable (N/A) to a given study, that item was 
not counted in the total number of criteria.
Data extraction
A standard template was designed for data extraction of study 
and sample characteristics including study design, aim, loca-
tion, gender ratio, sport population, anxiety outcome and key 
findings. KG extracted the data and SMR reviewed them for 
consistency. For the meta-analysis, KG extracted a list of deter-
minants of anxiety (associated variables) in each study to assess 
viability for meta-analysis. Once a determinant was identified, 
KG extracted the relevant quantitative data, while OS-E and 
SMR reviewed for consistency.
Data analysis (meta-analysis)
Pooled effect sizes were estimated using Comprehensive 
Meta-Analysis (CMA) software V.3.3.070.19 Raw data (mean, 
SD and n) were sourced for determinants of anxiety. When raw 
data were unavailable, we used effect size data (r, OR, t, β and 
F values). Overall effect sizes were estimated using the stan-
dardised difference in means (d) because this could be calculated 
for all types of extracted data. When we could not enter effect 
size data directly into CMA (eg, β, F and t statistics), transfor-
mations were made into an r statistic.20 21 All meta-analyses used 
the random-effects model to account for within-study error and 
between-study variation. Though a minimum of two studies are 
needed to perform a meta-analysis,22 CMA software requires 
at least three studies to perform publication bias analysis,23 
hence we required three studies for inclusion in the overall (eg, 
non-subgroup) meta-analyses. An initial population compar-
ison (elite athletes compared with non-athletes) was conducted, 
followed by analysis of the determinant variables.
Subgroup and sensitivity analysis
Where applicable, we conducted subgroup analysis to assess 
effect sizes across different anxiety outcomes (generalised, trait, 
diagnosis and global anxiety/depression) and playing status 
(current vs former). As subgroup analysis calculates an estimated 
effect size for each subgroup, a minimum of two subgroups with 
two contributing studies each were required to conduct a statis-
tically sound analysis for a determinant.22 Additionally, sensi-
tivity analysis was conducted when significant heterogeneity was 
observed. Sensitivity analysis is a repeat of the initial analysis 
which substitutes alternate inclusion or exclusion decisions to 
assess robustness of the results.24 Sensitivity analysis was calcu-
lated by removing any visual outliers or studies with dissimilar 
characteristics.
Interpretation of forest plots
A forest plot is a visual representation of the effect size for each 
study, represented by squares, and the overall estimated effect 
size, represented by a diamond. The side of the forest plot on 
which the effect size estimate falls indicates a higher anxiety 
score in that group. For plots with subgroup analysis, overall 
effect size estimates are reported in the text.
heterogeneity and publication bias
The Q statistic measured the presence or absence of heteroge-
neity by testing the null hypothesis of no variation in true effect 
size across studies.25 Heterogeneity was assumed when the Q 
statistic was significant, as the null hypothesis of no variation 
is rejected. The I2 statistic describes the proportion of variance 
in observed effects due to variance in true effects and can be 
interpreted as the percentage of variance that would remain 
if there was no sampling error.26 Low I2 scores indicate lower 
heterogeneity. Publication bias was assessed using the Duval and 
Tweedie trim-and-fill funnel plot method.27 A funnel plot is a 
graphical representation of study size as a function of effect size; 
large studies generally appear at the top of the graph, close to 
the mean effect size, and small studies typically appear at the 
bottom of the graph, spread broadly around the mean effect 
size.28 Asymmetry in funnel plots (more studies falling to one 
side of the graph) indicates potential publication bias. To assess 
the scope of bias, the trim-and-fill method estimates the number 
of missing studies in an asymmetrical plot, balances it with the 
‘fill’ of additional study points and recalculates the estimated 
effect size using the filled estimates.27
rESulTS
literature search
The database search returned 1163 articles (figure 1). After 
removal of duplicates, 1111 articles were screened for eligibility. 
Of the resulting 145 eligible articles, 61 were included in the 
narrative synthesis after full-text assessment. These articles are 
listed and grouped by anxiety outcome measure in table 1.
Description of included studies
Table 2 summarises the study characteristics of the reviewed arti-
cles (see online supplementary table 2 for a detailed summary 
of study characteristics for each article). Of the 61 studies, 46 
(75%) were published from 2014 onwards. Samples typically 
represented athletes from multiple countries (n=16, 26.2%). 
For single-location samples, the most common country was the 
USA (n=13, 21.3%), followed by Australia, France, Germany 
and Ireland with three studies each (5.0%). Italy, Korea, Spain, 
Sweden and Switzerland appeared twice (3.3%), and Canada, 
China, Denmark, Egypt, Israel, Netherlands, Norway, Tunisia, 
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Figure 1 PRISMA study selection flow chart.
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Meta-analysis
Of the 61 articles, 27 (44%) were suitable for meta-analysis. After 
screening for determinants of anxiety, seven variables were iden-
tified: one population comparison (athletes vs non-athletes) and 
six determinant variables (gender, age, concussion, musculoskeletal 
injury, career dissatisfaction—typically measured as a dichotomous 
‘yes/no’ variable, and recent adverse life events such as ‘death of 
close friend’ or ‘change in financial state’ within the past 6 months).
Five studies examined athletes compared with non-athletes.29–33 
No differences in anxiety symptomology were observed between 
athletes and non-athletes (d=−0.11, p=0.28; see figure 2). Sepa-
rate subgroup analysis of anxiety outcomes found no differences 
in generalised anxiety (d=−0.04, p=0.36) or trait anxiety scores 
(d=0.07, p=0.74). There was significant heterogeneity (p<0.01), 
which became non-significant after removal of two studies that had 
mixed sport samples (Q=5.810, p=0.06; d=−0.06, p=0.798). 
There was no evidence of publication bias.
Demographic determinants
Ten articles measured anxiety by gender.3 31 33–40 Overall, female 
athletes reported higher anxiety scores compared with male 
athletes (d=0.38, p<0.001). Moderate effect sizes were found 
across all anxiety measurement types (see figure 3). Homoge-
neity was upheld for the overall analysis and trait anxiety anal-
yses, but not the general anxiety (p=0.047) or diagnosis analyses 
(p=0.045). Homogeneity was achieved for general anxiety after 
removing the only single-sport sample (Q=1.658, p=0.437; 
d=0.28, p<0.001),33 though could not be reached for diagnosis 
as there were only two contributing studies. No publication bias 
was detected.
Three articles analysed anxiety by age.36 41 42 Younger athletes 
(<25 years) had higher anxiety levels compared with older athletes 
(>25 years; d=−0.34, p=0.003; figure 4). There were insuffi-
cient studies to perform subgroup analysis for anxiety outcomes. 
Heterogeneity and publication bias were not detected.
Concussion and musculoskeletal injury
Four articles examined anxiety by concussion frequency and symp-
tomology.43–46 Figure 5 denotes a non-significant effect of concus-
sion (d=0.33, p=0.053). There was significant heterogeneity that 
became non-significant after visual inspection advocated removal 
of an outlier study.43 The removal of the study also led to a small 
significant effect (d=0.17, p=0.023), where athletes with concus-
sion history showed higher anxiety symptoms. There was no 
evidence of publication bias in the initial analysis, though there was 
evidence after the outlier study was removed. Accordingly, these 
results should be interpreted cautiously.
Nine studies measured anxiety by musculoskeletal injury prev-
alence.33 35 40 41 47–51 An overall significant small-moderate effect 
indicated injured athletes reported higher levels of anxiety (d=0.31, 
p<0.001). Subgroup analyses indicated significant effects across all 
anxiety outcomes (see figure 6). Homogeneity was upheld across 
all analyses. There was evidence of publication bias, marginally 




ay 2019 by guest. Protected by copyright.
http://bjsm.bmj.com/
Br J Sports M
ed: first published as 10.1136/bjsports-2019-100620 on 16 May 2019. Downloaded from 
4 of 10 Rice SM, et al. Br J Sports Med 2019;53:722–730. doi:10.1136/bjsports-2019-100620
Systematic review
Table 2 Summary of included article characteristics
Types of athletes Sample characteristics
National level* 17 (27.8%) Mean sample size (n) 444
Collegiate/university 15 (24.6%) Median sample size (n) 217
Professional 15 (24.6%) Mean age of sample (years) 24.5
Mixed levels 7 (11.5%) Median age of sample 
(years)
23.9
Professional youth 4 (6.6%) Mean retirement length 
(years)
5.9
Olympic 3 (4.9%) Aggregate sample size 27 515
Types of sports Aggregate male athletes 16 547 (60%)
Multiple 29 (48%) Aggregate female athletes 7964 (28.9%)
Soccer 13 (21%) Study design
Rugby 5 (8%) Cross-sectional 36 (59%)
Basketball 3 (5%) Cohort 17 (28%)
Track and field 3 (5%) Longitudinal 2 (3%)
Gaelic sports (eg, hurling) 2 (3%) Experimental 2 (3%)
American football 1 (2%) Quasi-experimental 2 (3%)
Baseball 1 (2%) Randomised clinical trial 1 (2%)
Golf 1 (2%) Mixed design 1 (2%)
Ice hockey 1 (2%)  
Swimming 1 (2%)  
*One sample included national rookies.
Figure 2 Forest plot for anxiety in athletes and non-athletes.
Career dissatisfaction and recent adverse life events
Six articles analysed anxiety by career dissatisfaction.41 48 50–53 
Athletes with higher ratings of career dissatisfaction reported 
higher global anxiety/depression scores compared with career-sat-
isfied athletes (d=0.45, p<0.01; figure 7). Heterogeneity was 
observed, though became non-significant after the removal of the 
only study with a retired athlete sample (Q=6.348, p=0.175; 
d=0.55, p<0.001).53 Publication bias was detected, slightly 
reducing the estimated effect size (d=0.45).
Five studies examined anxiety by recent adverse life events.50–54 
Figure 8 shows a small effect of recent adverse life events on global 
anxiety/depression, where higher anxiety scores were found in 
athletes who had experienced one or more recent adverse life 
events (d=0.26, p<0.001). There was no evidence of heteroge-
neity or publication bias. Exploratory subgroup analysis of current 
versus former athletes found a small effect for former athletes 
(d=0.26, p<0.001, k=2),53 54 but not current athletes (d=0.23, 
p=0.113, k=3).50–52
narrative results
Online supplementary table 3 summarises key findings of each of 
the 61 articles. The following sections summarise other results not 
included in the meta-analysis.
Comorbidities
Diagnosed comorbidity was found for GAD occurring with depres-
sion,42 and for multiple anxiety disorders occurring together, for 
example GAD occurring with OCD, with agoraphobia or with 
panic disorder.3 For symptomatology, higher anxiety scores were 
commonly associated with higher depressive symptoms.40 46 Self-re-
ported history of mental health disorders was also associated with 
higher self-reported generalised anxiety symptoms in rugby players 
during a competitive season and training season.55 Comorbidity 
of common mental health symptoms (including global anxiety/
depression) was examined across multiple studies; however, due to 
non-specific reporting, it cannot be determined if indicated comor-
bidity encompassed anxiety symptoms.12 44 48 50 51 56–61
Competitive level and experience
Elite athletes playing at higher competitive levels typically reported 
fewer symptoms of anxiety than athletes in lower competitive 
ranks,42 62 63 for instance, first-league compared with second-
league soccer and basketball players.42 62 Similarly, basketball and 
soccer players with more years of playing experience exhibited 
lower anxiety scores than athletes with less experience.42 62 Lastly, 
trait anxiety scores were lower in high-ranked compared with 
low-ranked professional golfers,64 although not in high-ranked and 
low-ranked baseball players.65
Motivation and coping
Two studies measuring team-sport athletes (eg, football, hurling) 
reported a negative correlation between trait anxiety and several 
measures of motivation, including autonomy, integrated regulation 
(behaviours congruent with one’s value system) and intrinsic moti-
vation (actions that produce satisfaction from participation).39 66 
Trait anxiety was also positively correlated with non-regulated 
motivation (lack of intention to perform an action).66 Combined 
team and individual sport athletes with panic disorder were less 
likely to use social support coping, positive reinterpretation (reap-
praising an adverse situation in an optimistic way) and information 
seeking compared with athletes without that diagnosis.67 Athletes 
with GAD also reported low social support coping and informa-
tion seeking, while athletes with specific phobias indicated high 
self-blame, helplessness and emotion-focused coping (eg, regu-
lating distress with relaxation techniques).67
Neurological and biological factors
Tension/anxiety, exemplified by uneasiness and nervousness,68 
was negatively correlated with frontal alpha-asymmetries detected 
on electroencephalography (EEG) in soccer and American foot-
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Figure 3 Subgroup analyses for anxiety outcomes in male and female athletes.
Figure 4 Forest plot for anxiety among athletes older and younger than 25 years.
Tension/anxiety was also higher in team-sport athletes with an 
l/l genotype compared with an s/s genotype for the 5-HTTLPR 
serotonin transporter.70 Symptoms of generalised anxiety were 
negatively correlated with several markers of omega-3 polyunsat-
urated fatty acids, including blood levels of eicosapentaenoic acid, 
docosapentaenoic acid and HS-omega-3 indices, in athletes across 
a range of sports (basketball, soccer, rifle, and golf).71
Performance
Trait anxiety was negatively associated with performance in two 
studies, one regarding race times for long-distance runners72 and 
the other regarding performance errors following a competitive 
motor task in collegiate athletes.73 For state anxiety, accurate 
performance feedback from an experimenter was associated with 
lower anxiety shortly after a competitive task, whereas low feed-
back was associated with a short-term increase in state anxiety 
for rowing and cross-country athletes.74 Similarly, ‘optimal’ state 
anxiety (dependent on an athlete’s recollection) was associated 
with high performance in track and field athletes.75
Sport type
Comparisons across sport types were rarely reported in the 
included literature. One study found that aesthetic sport athletes 
(eg, gymnastics, figure skating) had the highest rates of GAD, 
while risk sports (eg, aerial sports, motor sports) had the lowest 
rates in both male and female athletes.3 One study found handball 
players had higher state and trait anxiety compared with volley-
ball players.30 Lastly, no differences in state and trait anxiety were 
found between team-sport and individual-sport athletes.76
Quality appraisal (risk of bias)
For full quality appraisal, see online supplementary files 4–9e. 
The overall appraisal score (as a proportion) for all studies was 
0.8. Articles were typically of high quality, with 41 articles (67%) 
scoring 0.8 and above. Nineteen articles (31%) were of moderate 
methodological quality (0.5–0.79), and one article (2%) was of 
poor methodological quality (<0.5). No studies were excluded 
based on these analyses.
DISCuSSIOn
The present study sought to identify determinants of anxiety 
symptoms and disorders among elite athletes, in addition to 
summarising the extant literature on this population to date. 
As noted by others,77 findings of this review highlight a rapid 
increase in this research domain, with 75% (n=46) of included 
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Figure 5 Forest plot for anxiety in athletes with and without concussion history.
Figure 6 Subgroup analyses for anxiety outcomes in injured and uninjured athletes.
outcomes indicated several general factors as being salient to 
symptomatic anxiety in elite athletes, including female gender, 
younger age and recent experience of adverse life events. These 
factors are consistent with findings from a recent meta-analysis 
for competitive anxiety in athletes,14 and trends in the general 
population.14 78 79 Meta-analysis also indicated the role of two 
athlete-specific factors, namely current musculoskeletal injury 
and sporting career dissatisfaction, as being associated with 
anxiety symptoms. This is the first meta-analysis to highlight 
these domains as potential risk factors for symptomatic anxiety 
among elite athletes.
Considering the athlete-specific factors, musculoskeletal 
injury and career dissatisfaction can be understood as promi-
nently biopsychosocial influencers of mental health.80 Attention 
to these factors, when present for elite athletes, may assist sports 
medicine practitioners in planning for the psychological manage-
ment needs of athlete cohorts. While individual intervention may 
be required for affected athletes (eg, psychotherapy, pharmaco-
therapy), sport administrators and officials may also wish to 
consider the broader environmental factors that may contribute 
to athlete injury or career dissatisfaction. For example, systemic 
approaches may involve challenging once normative attitudes 
about the need for athletes to play or train though pain or injury 
in order to demonstrate resilience or ‘toughness’.81
Additionally, retirement status as an athlete-specific subgroup 
analysis indicated that experiencing recent adverse life events 
was associated with higher global anxiety/depression in former 
but not current athletes. Established support services for athletes 
that have transitioned out of elite sport should consider the pres-
ence and impact of recent adverse life events in this population 
as a potential risk factor of symptomatic anxiety.
Meta-analysis of the five studies that also reported data from 
a non-athlete control group29–33 indicated that athletes report 
anxiety symptoms at comparable severity with the general popu-
lation. Similarly, a recent meta-analysis identified that high-per-
formance athletes were no more likely than non-athletes to 
report mild to severe symptoms of depression.82 This is consistent 
with assertions that elite athletes are not necessarily protected 
from mental health symptoms by virtue of their sporting role,83 
strengthening the rationale for an increased focus on the mental 
health of this population, and the broader development of the 
field of sports mental health.84 85 Anxiety disorders (especially 
GAD and social anxiety) are relatively prevalent in the general 
population, and may be similarly so in elite athletes, although 
research into diagnosed disorders (relative to symptoms) in this 
population is lacking.
This study also examined a range of broader outcomes that 
were not suitable for inclusion in the meta-analysis. Unsurpris-
ingly, it was found that anxiety symptoms in elite athletes were 
associated with symptoms of depression,40 46 or a depression diag-
nosis,42 in addition to other concurrent anxiety disorder diag-
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Figure 7 Forest plot for anxiety in athletes with and without career dissatisfaction.
Figure 8 Forest plot for anxiety in athletes with and without adverse life events within six months.
athletes,42 62 63 and may have a negative relationship with both 
motivation39 66 and discrete aspects of sporting performance.72 73 
These findings further support the role of preventative or early 
intervention approaches in the management of anxiety disor-
ders in elite athletes, as this may lower the likelihood of devel-
oping comorbid mental health problems (such as depression), 
and increase the likelihood of motivation and performance 
remaining intact. Psychological factors considered essential for 
elite athletes successful at the highest levels include affect and 
self-regulation, maintaining motivation, self-confidence and 
adaptive coping strategies, alongside supportive interpersonal 
relationships.86 Development of and attention to such factors 
will almost certainly assist athletes in managing anxiety (either 
at the symptom or diagnostic level), and coupled with evidence-
based intervention (eg, cognitive behavioural therapy), should be 
considered by sports medicine practitioners and sports officials 
in supporting the mental health of athlete populations.
The overall mean age for participants in the included studies 
was 24.5 years, which is inclusive of several studies that incor-
porated recently retired athletes. For most Olympic and 
professional sports, the years of competitive elite competition 
directly overlap with the peak ages of onset for mental disor-
ders, with 75% of all mental disorders shown to emerge prior 
to age 25.87 As anxiety disorders account for a large proportion 
of the burden of disease among all mental health problems,88 
their presence among and impacts on elite athlete populations 
affords greater attention and action where needed. Younger 
populations are also known to experience particular barriers to 
accessing mental healthcare,89 and elite athletes have additional 
role-related barriers including concerns about stigma and the 
impact of disclosure and help-seeking on team selection.90 The 
development of youth-specific models of mental healthcare for 
those under 25 years has resulted in decreased stigma and service 
barriers, improving access to evidence-based intervention.91 
Athlete-specific models of care are emerging,92 and efforts to 
consolidate and expand such initiatives warrant the support of 
governing bodies, codes, and competitions.
limitations and future directions
We acknowledge several limitations. In general, the quality of 
study reporting was relatively high, suggesting an overall low 
risk of bias in the included studies. Nonetheless, a wide range 
of anxiety symptom rating scales were employed in the studies 
included in the meta-analysis. Where possible, we conducted 
subgroup analyses for measures differentiating trait, gener-
alised, global and diagnosed anxiety. Heterogeneity was initially 
observed for the gender, concussion and career dissatisfaction 
analyses, though resolved after inspection of sample-specific 
differences (eg, differences between sports). Additionally, only 
a small proportion of the included studies reported a confirmed 
clinician-rated or interviewer-rated diagnosis of anxiety, with 
most studies employing self-reported symptoms. Distinguishing 
anxiety symptoms from diagnostic disorders is important given 
functional impairment and associated distress is likely to be 
more severe in the latter. Studies examining outcomes of athletes 
within the clinical range for anxiety disorders are currently 
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to examine potential group differences according to clinician or 
interviewer-rated diagnoses of anxiety versus self-report symp-
toms, given there may be bias in self-report measures, either in 
terms of under-reporting or over-reporting.93 Further, attention 
should be given to patterns of symptom onset, duration, severity 
and associated distress4 in order to distinguish anxiety disorders 
from competition-based performance anxiety.
While a relatively large number of studies were included in 
this review, only one study reported on the effects of an inter-
vention, and there were only a handful of studies using a longitu-
dinal design. The single included intervention study was a small 
RCT testing a mindfulness-acceptance–based approach.94 While 
other groups have developed athlete-specific mental health 
interventions (eg, the athlete optimisation approach for college 
athletes of Donohue et al),92 anxiety outcomes of these inter-
ventions are yet to be explored. The present results highlight 
the urgent need for well-conducted intervention-based RCTs, 
and specific attention towards the acceptability and efficacy of 
psychotherapy approaches among elite athletes is needed. Simi-
larly, longitudinal studies in elite athlete populations are needed 
to shed light on anxiety symptom patterns according to temporal 
factors. Related to this, the present study was unable to conclude 
whether time in competitive season impacted outcomes. It is 
possible that a seasonal effect of athlete anxiety may exist in 
line with peak training loads, recovery and proximity to major 
competition.95
The present review discovered markedly higher symptom-
atic anxiety among female athletes than their male counter-
parts. Emerging research suggests that younger males, who can 
be socialised to deny or suppress perceived vulnerabilities in 
sport settings,96 may exhibit mental health symptoms through a 
constellation of behaviours beyond those included in diagnostic 
criteria for internalising disorders such as anxiety.97 98 Research 
attention to anxiety symptoms (which are known to be higher 
in females), in the context of broader comorbidity domains 
of risk-taking, problematic anger or aggression, and substance 
misuse (which are known to be higher in males),99 100 may be an 
important step in recognising athletes at risk of mental health 
symptoms or disorders who may otherwise go unidentified via 
existing anxiety rating scales or diagnostic criteria.
Further, the present study identified an under-representa-
tion of female athletes and para-athletes. The ratio of males to 
females was roughly double, and only one article reported data 
for para-athletes.32 Future research should aim to explore these 
samples. Additionally, some factors pertinent to mental health 
are yet to be examined, including athlete sexuality and ethnicity. 
Future studies should consider these factors given consistent 
findings that minority sexuality and ethnicity differently impact 
mental health.101 102
To date, studies are yet to conclusively determine cross-sport 
comparisons for anxiety disorders in elite athletes. The main 
exceptions to this are work by Schaal and colleagues,3 who found 
higher rates of GAD among elite athletes competing in aesthetic 
sports, and work by Levit and colleagues,76 who found no 
differences in anxiety symptoms between team-based and indi-
vidual athletes. Comparatively, growing literature of depression 
in elite athletes suggests that individual-sport athletes exhibit 
higher depressive symptoms than team-sport athletes.3 103 Future 
comparisons are needed, particularly taking account of the rela-
tive contribution of general versus athlete-specific factors in this 
regard. Future studies using meta-regression techniques may 
help quantify the unique contribution of athlete-specific factors.
Any link between the presence of an anxiety disorder or 
anxiety symptoms and competitive performance impacts is 
not yet well understood. As an extension, it is unclear whether 
athlete-specific interventions that provide remission of anxiety 
symptoms may be associated with changes in performance. 
Furthermore, while GAD and generalised anxiety symptoms 
were well addressed in this review, at present we know far less 
about other anxiety disorders (eg, OCD, panic disorder, social 
phobia) and a related personality disorder (ie, obsessive-com-
pulsive personality disorder; OCPD) in elite athletes. Ritualistic 
behaviours or routines are common among elite athletes,86 and 
potential overlap between such behaviours and anxiety disor-
ders, especially OCD and OCPD, remains poorly understood.
Finally, additional research is needed on neurological or 
biological aspects of anxiety in elite athletes. There was a rela-
tive lack of attention to this among included studies, and such 
research could consider EEG profiles,69 or imaging approaches, 
the effects of biotherapeutic agents such as omega-3 polyun-
saturated fatty acids71 or cannabidiol, which is currently not a 
prohibited substance for athletes,104 and genomics and related 
hereditary analytic approaches.104
Conclusions
Factors associated with anxiety symptoms among elite athletes 
provide useful information for preventative intervention or 
acute phase management. While there are research gaps related 
to particular subtypes of anxiety in elite populations (eg, OCD, 
panic disorder), this review highlights both general factors and 
athlete-specific factors associated with symptom burden. Though 
data are lacking, it seems feasible that focused and acceptable 
interventions for anxiety symptoms among athlete populations 
may enhance career longevity and improve role satisfaction. 
Youth-specific models of mental healthcare that have been estab-
lished internationally are likely to be useful for those aiming to 
develop innovative athlete-specific services. While it remains 
to be seen whether such approaches will improve sporting or 
athletic performance, the next decade is certain to see major 
investment into the mental health of athletes and expansion of 
sports mental health as a discipline.
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